Denosumab: in cancer treatment-induced bone loss.
Muir, Victoria J
Denosumab: in cancer treatment-induced bone loss. [electronic resource] - BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy Dec 2010 - 379-86 p. digital
Publication Type: Journal Article; Review
1179-190X
10.2165/11203310-000000000-00000 doi
Adult
Animals
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Breast Neoplasms--therapy
Clinical Trials as Topic
Denosumab
Dose-Response Relationship, Drug
Female
Fractures, Bone--etiology
Humans
Male
Osteoporosis--drug therapy
Prostatic Neoplasms--therapy
RANK Ligand--administration & dosage
Denosumab: in cancer treatment-induced bone loss. [electronic resource] - BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy Dec 2010 - 379-86 p. digital
Publication Type: Journal Article; Review
1179-190X
10.2165/11203310-000000000-00000 doi
Adult
Animals
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Breast Neoplasms--therapy
Clinical Trials as Topic
Denosumab
Dose-Response Relationship, Drug
Female
Fractures, Bone--etiology
Humans
Male
Osteoporosis--drug therapy
Prostatic Neoplasms--therapy
RANK Ligand--administration & dosage